Blog
Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates
Eton Pharmaceuticals, Inc. (ETON) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to loss of $0.03 per share a year ago
Fate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates
Fate Therapeutics (FATE) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to loss of $0.47 per share a year ago. These figures
Gevo, Inc. (GEVO) Reports Q1 Loss, Tops Revenue Estimates
Gevo, Inc. (GEVO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.08 per share a year ago. These figures are
Genasys (GNSS) Reports Q2 Loss, Lags Revenue Estimates
Genasys (GNSS) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.16 per share a year ago. These figures are
Biodesix, Inc. (BDSX) Reports Q1 Loss, Misses Revenue Estimates
Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.08 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.14 per share a year ago. These figures are adjusted for
Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates
Lineage Cell (LCTX) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.04 per share a year ago. These figures are adjusted for
Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Lags Revenue Estimates
Lexicon Pharmaceuticals (LXRX) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.20 per share a year ago. These
Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Misses Revenue Estimates
Spero Therapeutics, Inc. (SPRO) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $0.24 per share a year ago. These
Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue Estimates
Dare Bioscience, Inc. (DARE) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to loss of $0.84 per share a year ago. These
Stocks on the Move: FSLR, CRWV, OKLO
Wall Street Uncertainty Vanishes
Wall Street hates uncertainty, and this week, the two biggest uncertainties facing investors vanished – the trade war with China and inflationary concerns. Though
Do Options Traders Know Something About Burlington Stores Stock We Don't?
Investors in Burlington Stores, Inc. BURL need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $170.00 Call had some of the highest
Top Stock Reports for Microsoft, Amazon.com & Mastercard
Tuesday, May 13, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft
Trump's EO Targets Big Pharma Stocks like Eli Lilly
Everybody was cheering about the deal the US made with China over the weekend but there was another big announcement this weekend as well. President Trump signed an Executive Order aimed at stopping
3 Highly Ranked Gold Stocks to Buy on the Dip: AEM, EQX, HMY
With the U.S. and China striking a trade deal on Monday, the price of gold has dipped from its historic highs of over $3,400 per ounce. Although investor sentiment is turning bullish on optimism
Are Options Traders Betting on a Big Move in Warby Parker (WRBY) Stock?
Investors in Warby Parker Inc. WRBY need to pay close attention to the stock based on moves in the options market lately. That is because the June 20, 2025 $10 Call had some of the highest implied
Is the Options Market Predicting a Spike in Wynn Resorts (WYNN) Stock?
Investors in Wynn Resorts, Limited WYNN need to pay close attention to the stock based on moves in the options market lately. That is because the June 20, 2025 $47.5 Call had some of the highest
Top-Ranked Momentum Stocks to Buy Now and How to Find Them
Stocks soared on Monday, sending the Nasdaq into a new bull market as Wall Street rushed to buy stocks after news broke late Sunday night that the U.S. and China agreed to de-escalate the tariff
Is the Options Market Predicting a Spike in Zillow Stock?
Investors in Zillow Group, Inc. Z need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $30.00 Call had some of the highest implied
WLFC's Q1 Earnings Decline Y/Y on Rising G&A Costs, Stock Down 10%
Shares of Willis Lease Finance Corporation WLFC have declined 9.5% since the company reported its earnings for the quarter ended March 31, 2025, underperforming the S&P 500 index, which dipped just
Meritage Hospitality Group Inc. (MHGU) Reports Q1 Loss, Tops Revenue Estimates
Meritage Hospitality Group Inc. (MHGU) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to earnings of $0.11 per share a year
TWIN Stock Up 6% Despite Incurring Loss in Q3 Due to High Expenses
Shares of Twin Disc, Incorporated TWIN have gained 6.2% since the company reported its fiscal third quarter results, notably outperforming the broader market. Over the same time frame, the S&P 500
LYFT Q1 Earnings & Revenues Miss, Gross Bookings Rise Y/Y
Lyft Inc. (LYFT) reported first-quarter 2025 earnings of 19 cents per share, which missed the Zacks Consensus Estimate of 20 cents and improved year over year.
Revenues of $1.45 billion missed the
RTX's PhantomStrike Radar Catches Spotlight: Should You Buy the Stock Now?
RTX Corp. RTX recently revealed that its PhantomStrike radar has completed its inaugural flight test in Ontario, CA. During the test, PhantomStrike effectively tracked multiple airborne targets and




